Categories: US FDA Approval

Lupin gets USFDA nod for generic version of Mycobutin capsules

The drug is used for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection

New Delhi February 28, 2014:- Pharmaceutical firm Lupin Ltd. on Wednesday said it has received final approval from the US health regulator to market the generic version of Mycobutin capsules of Pharmacia and Upjohn Co. that are used while treating advance HIV infection.
The approval from the US Food and Drug Administration (FDA) is forRifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
“Lupin Pharmaceuticals Inc. (LPI), the company’s US subsidiary would commence marketing the product shortly,” it said further.
The drug is used for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.

Lupin’s Rifabutin capsules are generic equivalent of Pharmacia and Upjohn Co.’s Mycobutin capsules. Headquartered in Baltimore, Maryland, Lupin is the 5th largest generics player in the US and third in Japan and South Africa. PTI 

The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau
11 years ago

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago